Tetraphase Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
September 03 2019 - 8:00AM
Business Wire
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a
biopharmaceutical company focused on commercializing its novel
tetracycline XERAVATM (eravacycline for injection) to treat serious
and life-threatening infections, today announced that senior
management will present a corporate overview at the H. C.
Wainwright and Company 21st Annual Global Investment Conference on
Monday, September 9, 2019 at 2:35 p.m. ET at the Lotte New York
Palace Hotel in New York City.
A live audio webcast of the H.C. Wainwright Global Investment
Conference presentation will be available on the Company’s website
at https://tphase.gcs-web.com/events-presentations. The archived
presentation will be available for 30 days.
About Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc., is a biopharmaceutical company
using its proprietary chemistry technology to create novel
tetracyclines for serious and life-threatening conditions,
including infections caused by many of the multidrug-resistant
bacteria highlighted as urgent public health threats by the World
Health Organization and the Centers for Disease Control and
Prevention. The Company has created more than 3,000 novel
tetracycline compounds using its proprietary technology platform.
Tetraphase's lead product XERAVA™ is approved for the treatment of
complicated intra-abdominal infections by the U.S. Food and Drug
Administration and the European Medicines Agency. The Company’s
pipeline also includes antibiotics TP-271 and TP-6076, which are
Phase 2 ready, and TP-2846, which is in preclinical testing for
acute myeloid leukemia. The Company intends to out license its
pipeline candidates. Please visit www.tphase.com for more company
information.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190903005017/en/
Argot Partners Maeve Conneighton 212-600-1902
maeve@argotpartners.com
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2023 to Jul 2024